Skip to Main Content


Skip Nav Destination

Abstract P4-13-12: Everolimus plus trastuzumab and vinorelbine for trastuzumab-resistant, taxane-pretreated, HER2+ advanced breast cancer: Overall survival results from BOLERO-3

Cancer Res (2016) 76 (4_Supplement): P4-13-12.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Mariana Brandão
  • Noam F. Pondé
  • Francesca Poggio
  • Nuria Kotecki
  • Mauren Salis
  • Matteo Lambertini
  • Evandro de Azambuja
Expert Review of Anticancer Therapy (2018) 18 (7): 629.
Close Modal

or Create an Account

Close Modal
Close Modal